Piece of paper… [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2012-12-03 08:19 (4939 d 16:47 ago) – Posting: # 9656
Views: 11,587

Hi Helmut,

good info, thanks a lot.

PSRtPH = Potential Serious Risk to Public Health = the regulated term for the dark matter from which referrals are made.

❝ A term for the stage should be included in the ANOVA model. However, the guideline does not clarify what the consequence should be if it is statistically significant. In principle, the data sets of both stages could not be combined.


We cannot combine data for stage 1 an stage 2 in our analyses, or what is meant there?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
144 visitors (0 registered, 144 guests [including 55 identified bots]).
Forum time: 02:06 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5